D E Stableforth

3.2k total citations
73 papers, 2.0k citations indexed

About

D E Stableforth is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, D E Stableforth has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in D E Stableforth's work include Cystic Fibrosis Research Advances (30 papers), Tracheal and airway disorders (9 papers) and Transplantation: Methods and Outcomes (6 papers). D E Stableforth is often cited by papers focused on Cystic Fibrosis Research Advances (30 papers), Tracheal and airway disorders (9 papers) and Transplantation: Methods and Outcomes (6 papers). D E Stableforth collaborates with scholars based in United Kingdom, Tunisia and Australia. D E Stableforth's co-authors include L.P. Ormerod, F. Edenborough, M. Mulheran, Dev Banerjee, David L. Smith, R.M. Cayton, W. E. Mackenzie, Sarah Lewis, Alan J. Knox and Alan R Smyth and has published in prestigious journals such as The Lancet, Journal of Allergy and Clinical Immunology and Journal of Clinical Microbiology.

In The Last Decade

D E Stableforth

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D E Stableforth United Kingdom 24 1.4k 437 371 223 160 73 2.0k
Stanley B. Fiel United States 20 1.0k 0.8× 242 0.6× 232 0.6× 108 0.5× 153 1.0× 42 1.4k
R Dinwiddie United Kingdom 27 1.5k 1.1× 416 1.0× 312 0.8× 413 1.9× 146 0.9× 89 2.3k
Ari Lindqvist Finland 28 1.2k 0.8× 972 2.2× 227 0.6× 142 0.6× 89 0.6× 92 2.2k
Christopher M. Oermann United States 22 1.6k 1.2× 230 0.5× 460 1.2× 103 0.5× 206 1.3× 59 2.0k
Salvador Quintana Spain 21 864 0.6× 247 0.6× 677 1.8× 367 1.6× 82 0.5× 81 2.3k
Stacey C. FitzSimmons United States 20 2.4k 1.8× 235 0.5× 324 0.9× 631 2.8× 225 1.4× 27 3.2k
K. Brownlee United Kingdom 23 1.7k 1.2× 177 0.4× 334 0.9× 255 1.1× 269 1.7× 67 2.2k
David L. Bowton United States 22 625 0.5× 200 0.5× 468 1.3× 337 1.5× 137 0.9× 52 1.8k
Don B. Sanders United States 27 2.0k 1.4× 219 0.5× 489 1.3× 125 0.6× 210 1.3× 113 2.6k
Luc Huyghens Belgium 25 414 0.3× 223 0.5× 546 1.5× 309 1.4× 185 1.2× 88 2.3k

Countries citing papers authored by D E Stableforth

Since Specialization
Citations

This map shows the geographic impact of D E Stableforth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Stableforth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Stableforth more than expected).

Fields of papers citing papers by D E Stableforth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D E Stableforth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Stableforth. The network helps show where D E Stableforth may publish in the future.

Co-authorship network of co-authors of D E Stableforth

This figure shows the co-authorship network connecting the top 25 collaborators of D E Stableforth. A scholar is included among the top collaborators of D E Stableforth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D E Stableforth. D E Stableforth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nikander, Kurt, John Denyer, Mary Dodd, et al.. (2010). The Adaptive Aerosol Delivery System in a Telehealth Setting: Patient Acceptance, Performance and Feasibility. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(s1). S–21. 11 indexed citations
2.
Milkiewicz, Piotr, G. Skiba, Déirdre Kelly, et al.. (2002). Transplantation for cystic fibrosis: Outcome following early liver transplantation. Journal of Gastroenterology and Hepatology. 17(2). 208–213. 77 indexed citations
3.
Banerjee, Dev, Andrew R. Clamp, & D E Stableforth. (2001). A political asylum seeker with an amoebic empyema in Birmingham. Hospital Medicine. 62(6). 372–373. 1 indexed citations
4.
Shah, Pallav L., Steven Conway, Sandra Scott, et al.. (2001). A Case-Controlled Study with Dornase Alfa to Evaluate Impact on Disease Progression over a 4-Year Period. Respiration. 68(2). 160–164. 23 indexed citations
5.
Mulheran, M., Christopher Degg, S Burr, Douglas W. Morgan, & D E Stableforth. (2001). Occurrence and Risk of Cochleotoxicity in Cystic Fibrosis Patients Receiving Repeated High-Dose Aminoglycoside Therapy. Antimicrobial Agents and Chemotherapy. 45(9). 2502–2509. 78 indexed citations
6.
Edenborough, F., W. E. Mackenzie, & D E Stableforth. (2000). The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977–1996. BJOG An International Journal of Obstetrics & Gynaecology. 107(2). 254–261. 75 indexed citations
7.
Hill, A. T., R. B. Hopkinson, & D E Stableforth. (1998). Ventilation in a Birmingham intensive care unit 1993–1995: outcome for patients with chronic obstructive pulmonary disease. Respiratory Medicine. 92(2). 156–161. 40 indexed citations
8.
Smith, Anthony W., Peter A. Lambert, D. Peckham, et al.. (1997). Serum IgG response to an outer membrane porin protein ofBurkholderia cepaciain patients with cystic fibrosis. FEMS Immunology & Medical Microbiology. 17(2). 87–94. 4 indexed citations
9.
Smith, David L., et al.. (1993). Epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis and the use of strain genotyping. Journal of Infection. 26(3). 325–331. 14 indexed citations
10.
Stableforth, D E, et al.. (1993). Endurance exercise capacity in adults with cystic fibrosis. Respiratory Medicine. 87(7). 541–549. 19 indexed citations
11.
Hall, S. K., et al.. (1990). Sweat Sodium and Chloride Concentrations—Essential Criteria for the Diagnosis of Cystic Fibrosis in Adults. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 27(4). 318–320. 38 indexed citations
12.
Burge, Sherwood, et al.. (1988). The effects of ketotifen on beta-adrenergic activity in asthmatics. European Journal of Clinical Pharmacology. 34(6). 585–589. 1 indexed citations
13.
Williams, Alan J., P Asquith, & D E Stableforth. (1988). Susceptibility to tuberculosis in patients with coeliac disease. Tubercle. 69(4). 267–274. 12 indexed citations
14.
Osman, J, P Ormerod, & D E Stableforth. (1987). Management of acute asthma: A survey of hospital practice and comparison between thoracic and general physicians in Birmingham and Manchester. British Journal of Diseases of the Chest. 81(3). 232–241. 31 indexed citations
15.
Wiggins, James W., et al.. (1985). A study of the use of ultrasonically nebulized lignocaine for local anaesthesia during fibreoptic bronchoscopy. British Journal of Diseases of the Chest. 79(1). 49–59. 23 indexed citations
16.
Johnson, Annette J., Andrew Nunn, A.R. Somner, D E Stableforth, & C.J. Stewart. (1984). Circumstances of death from asthma.. BMJ. 288(6434). 1870–1872. 97 indexed citations
17.
Bali, A, D E Stableforth, & P Asquith. (1983). Prolonged small-intestinal transit time in cystic fibrosis.. BMJ. 287(6398). 1011–1013. 78 indexed citations
18.
19.
Ormerod, L.P. & D E Stableforth. (1980). Asthma mortality in Birmingham 1975-7: 53 deaths.. BMJ. 280(6215). 687–690. 108 indexed citations
20.
Kundi, Michael, et al.. (1977). VENOUS THROMBOSIS, HEPARIN-INDUCED ANTITHROMBIN m DEFICIENCY, AND FACTOR VIII. The Lancet. 310(8050). 1231–1232. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley B. Fiel Breakdown of academic impact, for papers by R Dinwiddie Breakdown of academic impact, for papers by Ari Lindqvist Breakdown of academic impact, for papers by Christopher M. Oermann Breakdown of academic impact, for papers by Salvador Quintana Breakdown of academic impact, for papers by Stacey C. FitzSimmons Breakdown of academic impact, for papers by K. Brownlee Breakdown of academic impact, for papers by David L. Bowton Breakdown of academic impact, for papers by Don B. Sanders Breakdown of academic impact, for papers by Luc Huyghens
Rankless by CCL
2026